Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions

Clinical Cardiology

Volumn 27, Issue 7, 2004, Pages 407-410

  Chao, Ting Hsing ^a   Li, Yi Heng ^a   Tsai, Wei Chuan ^a   Chen, Jyh Hong ^a,b   Liu, Ping Yen ^a   Tsai, Liang Miin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Inflammation; Percutaneous coronary intervention; Thrombomodulin

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; PROTEIN C; THROMBIN; THROMBOMODULIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENDOTHELIUM; FEMALE; HEART MUSCLE INJURY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUSCLE NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDY;

EID: 3042725341     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270708     Document Type: Article

References (17)

1. Esmon CT: Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995;9:946-955
2. Ishii H, Uchiyama H, Kazama M: Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991;65:618-623
3. Fager G: Thrombomodulin and proliferation of vascular smooth muscle cells. Circ Res 1995;77:645-650
4. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN: Circulating endothelial cell markers in peripheral vascular disease: Relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27:916-921
5. Blann AD, Amiral J, McCollum CN: Circulating endothelial cell/leukocyte adhesion molecules in ischemic heart disease. Br J Haematol 1996;95: 263-265
6. Li YH, Chen JH, Wu HL, Shi GY, Huang HC, Chao TH, Tsai WC, Tsai LM, Guo HR, Wu WS, Chen ZC: G-33A mutation in the promotor region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels. Am J Cardiol 2000;85:8-12
7. Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A: Postangioplasty restenosis: Platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 1997;133: 387-392
8. Ross R, Glomset JA: Atherosclerosis and the arterial smooth muscle cell. Science 1973;180:1332-1339
9. Blann AD, Amiral J, McCollum CN: Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischemic heart disease. Eur J Haematol 1997;59:115-120
10. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK: Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study. Lancet 1999;353:1729-1734
11. Oh JK, Shub C, llstrup DM, Reeder GS: Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J 1985; 109:1225-1231
12. Karim MA, Shinn MS, Oskarsson H, Windle J, Deligonul U: Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;76:521-523
13. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, Wu AH, Waters DD: Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 1997;80:1476-1478
14. Salvioni A, Galli S, Marenzi G, Lauri G, Perego GB, Assanelli E, Guazzi MD: Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1998;135:503-509
15. Bediner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ: Atherosclerosis: Basic mechanisms-oxidation, inflammation, and genetics. Circulation 1995;91:2488-2496
16. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S: Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991;84:1758-1772
17. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G: The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappa B and mitogen-activated protein kinase pathway. J Exp Med 2002;196:565-577